AREL1 resists the apoptosis induced by TGF‐β by inhibiting SMAC in vascular endothelial cells

Abstract

AbstractAbnormal apoptosis of vascular endothelial cells is an important feature of arteriosclerosis (AS). Here, we induced apoptosis in human umbilical vein endothelial cells (HUVECs) using transforming growth factor‐β (TGF‐β), and investigated the role of antiapoptotic E3 ubiquitin ligase (AREL1) in the apoptosis of vascular endothelial cells. We proved that AREL1 is downregulated in TGF‐β treated HUVECs. The overexpression of AREL1 inhibits the activation of Caspase‐3 and Caspase‐9 and attenuates cell apoptosis induced by TGF‐β. According to the result of coimmunoprecipitation, AREL1 interacts with the proapoptotic proteins the second mitochondria‐derived activator of caspases (SMAC) in TGF‐β treated HUVECs. In addition, miR‐320b inhibits the expression of AREL1, and the overexpression of AREL1 attenuates the apoptosis induced by miR‐320b mimics in HUVECs. In conclusion, AREL1 is downregulated by miR‐320b. AREL1 overexpression inhibits TGF‐β induced apoptosis through downregulating SMAC in vascular endothelial cells. Our study explores pathogenesis regulation mechanism and new biological therapeutic targets for vascular disease.